Detalhe da pesquisa
1.
Anti-GluA3 autoantibodies define a new sub-population of frontotemporal lobar degeneration patients with distinct neuropathological features.
Brain Behav Immun
; 118: 380-397, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38485064
2.
Detection of TDP-43 seeding activity in the olfactory mucosa from patients with frontotemporal dementia.
Alzheimers Dement
; 20(2): 1156-1165, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37908186
3.
Missense variants in RPH3A cause defects in excitatory synaptic function and are associated with a clinically variable neurodevelopmental disorder.
Genet Med
; 25(11): 100922, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37403762
4.
The development of ADAM10 endocytosis inhibitors for the treatment of Alzheimer's disease.
Mol Ther
; 30(7): 2474-2490, 2022 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35390543
5.
Dopamine Transmission Imbalance in Neuroinflammation: Perspectives on Long-Term COVID-19.
Int J Mol Sci
; 24(6)2023 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36982693
6.
Rabphilin-3A as a novel target to reverse α-synuclein-induced synaptic loss in Parkinson's disease.
Pharmacol Res
; 183: 106375, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35918045
7.
Dopamine-dependent early synaptic and motor dysfunctions induced by α-synuclein in the nigrostriatal circuit.
Brain
; 144(11): 3477-3491, 2021 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34297092
8.
Synaptic Neurofilaments and GluN1-Neurofilament Light Chain Interaction in Experimental Models of α-Synucleinopathies.
Neurodegener Dis
; 22(1): 7-14, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35940118
9.
Analysis of mRNA and Protein Levels of CAP2, DLG1 and ADAM10 Genes in Post-Mortem Brain of Schizophrenia, Parkinson's and Alzheimer's Disease Patients.
Int J Mol Sci
; 23(3)2022 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35163460
10.
GluA3-containing AMPA receptors: From physiology to synaptic dysfunction in brain disorders.
Neurobiol Dis
; 161: 105539, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34743951
11.
Transcranial Magnetic Stimulation Exerts "Rejuvenation" Effects on Corticostriatal Synapses after Partial Dopamine Depletion.
Mov Disord
; 36(10): 2254-2263, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34339069
12.
GluA3 autoantibodies induce alterations in dendritic spine and behavior in mice.
Brain Behav Immun
; 97: 89-101, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34246733
13.
Differential mechanisms of tolerance induced by NMDA and 3,5-dihydroxyphenylglycine (DHPG) preconditioning.
J Neurochem
; 155(6): 638-649, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32343420
14.
Low doses of Perampanel protect striatal and hippocampal neurons against in vitro ischemia by reversing the ischemia-induced alteration of AMPA receptor subunit composition.
Neurobiol Dis
; 140: 104848, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32222474
15.
Protease-activated receptor 1 (PAR1) inhibits synaptic NMDARs in mouse nigral dopaminergic neurons.
Pharmacol Res
; 160: 105185, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32891865
16.
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration.
Brain
; 142(5): 1365-1385, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30927362
17.
Synaptic GluN2A-Containing NMDA Receptors: From Physiology to Pathological Synaptic Plasticity.
Int J Mol Sci
; 21(4)2020 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32102377
18.
NMDA receptor GluN2D subunit participates to levodopa-induced dyskinesia pathophysiology.
Neurobiol Dis
; 121: 338-349, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30261285
19.
Glutamatergic mechanisms in L-DOPA-induced dyskinesia and therapeutic implications.
J Neural Transm (Vienna)
; 125(8): 1225-1236, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29387966
20.
Coxsackievirus Adenovirus Receptor Loss Impairs Adult Neurogenesis, Synapse Content, and Hippocampus Plasticity.
J Neurosci
; 36(37): 9558-71, 2016 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27629708